Qms Digoxin Reagent System On The Abbott Aeroset System
Enzyme Immunoassay, Digoxin. 510(k) K023058, from Seradyn (Indianapolis, IN). Product code KXT, class 2.
As of Nov 19, 2026, K023058 is an FDA 510(k) held by Seradyn, substantially equivalent on Oct 24, 2002 after 41 days, with no recalls tied to it in FDA's recall database.
- Review time: 41 days
- Recalls: 0
- Cited as a predicate by: 1 device
The SERADYN QMS™ DIGOXIN assay is used for the quantitation of digoxin in human serum or plasma on the Abbott AEROSET® System. Digoxin is a potent cardiac glycoside widely prescribed for the treatment of patients suffering from congestive heart failure, as well as some types of cardiac arrhythmias. Digoxin intoxication is a common and serious problem in the clinical setting.
- Boehringer Mannheim/Hitachi 917 AnalyzerK953239 · Boehringer Mannheim Corp. · Sep 25, 1995
- Architect Idigoxin and Architect Idigoxin Calibrators, Models 1P32-25 and IP32-01K082953 · Biokit, S.A. · Dec 22, 2008
- ADVIA Centaur® Digoxin assayK193397 · Siemens Healthcare Diagnostics, Inc. · Jul 16, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 13, 2002
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3320
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files